B-cell lymphoma medical therapy: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{B-cell lymphoma}} | {{B-cell lymphoma}} | ||
{{CMG}} | |||
==Overview== | |||
==Treatment== | |||
* Treatment includes radiation and chemotherapy. | |||
* Early-stage indolent B-cell lymphomas can often be treated with radiation alone, with long-term non-recurrence. | |||
* Early-stage aggressive disease is treated with chemotherapy and often radiation, with a 70-90% cure rate.<ref name="mmhe"/> | |||
* Late-stage indolent lymphomas are sometimes left untreated and monitored until they progress. | |||
* Late-stage aggressive disease is treated with chemotherapy, with cure rates of over 70%.<ref name="mmhe"/> | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} |
Revision as of 14:43, 20 August 2015
B-cell lymphoma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
B-cell lymphoma medical therapy On the Web |
American Roentgen Ray Society Images of B-cell lymphoma medical therapy |
Risk calculators and risk factors for B-cell lymphoma medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Treatment
- Treatment includes radiation and chemotherapy.
- Early-stage indolent B-cell lymphomas can often be treated with radiation alone, with long-term non-recurrence.
- Early-stage aggressive disease is treated with chemotherapy and often radiation, with a 70-90% cure rate.[1]
- Late-stage indolent lymphomas are sometimes left untreated and monitored until they progress.
- Late-stage aggressive disease is treated with chemotherapy, with cure rates of over 70%.[1]